The store will not work correctly when cookies are disabled.
(R)-methyl 1-(2-(1H-indol-3-yl)-2-oxoacetyl)pyrrolidine-2-carboxylate
ID: ALA3113611
PubChem CID: 76314095
Max Phase: Preclinical
Molecular Formula: C16H16N2O4
Molecular Weight: 300.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)[C@H]1CCCN1C(=O)C(=O)c1c[nH]c2ccccc12
Standard InChI: InChI=1S/C16H16N2O4/c1-22-16(21)13-7-4-8-18(13)15(20)14(19)11-9-17-12-6-3-2-5-10(11)12/h2-3,5-6,9,13,17H,4,7-8H2,1H3/t13-/m1/s1
Standard InChI Key: WRRZPBYFMHCXPZ-CYBMUJFWSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
32.0724 -21.5241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0712 -22.3515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7860 -22.7643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7842 -21.1114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4995 -21.5205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4999 -22.3515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2903 -22.6071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.7786 -21.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2894 -21.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6961 -20.5465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5211 -20.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2780 -19.8354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9393 -21.2511 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9278 -19.8222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7473 -19.7271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9123 -18.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1946 -18.5120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5860 -19.0690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3050 -20.3349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0575 -21.1219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.1103 -20.1558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6681 -20.7638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 1 0
10 12 2 0
11 13 2 0
11 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
15 19 1 6
19 20 2 0
19 21 1 0
21 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.31 | Molecular Weight (Monoisotopic): 300.1110 | AlogP: 1.51 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.47 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.30 | CX Basic pKa: ┄ | CX LogP: 1.47 | CX LogD: 1.47 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.53 | Np Likeness Score: -0.54 |
References
1. Prasher P, Pooja, Singh P.. (2014) Lead modification: amino acid appended indoles as highly effective 5-LOX inhibitors., 22 (5): [PMID:24508141] [10.1016/j.bmc.2014.01.027] |